Mehta et al., 2001 - Google Patents
Association between hepatitis C virus infection and diabetes mellitusMehta et al., 2001
View PDF- Document ID
- 11669717150690642234
- Author
- Mehta S
- Strathdee S
- Thomas D
- Publication year
- Publication venue
- Epidemiologic reviews
External Links
Snippet
A number of infectious agents have been linked to chronic diseases, including the linkages of human immunodeficiency virus with acquired immunodeficiency syndrome, Epstein-Barr virus with Burkitt's lymphoma, human papillomavirus with cervical cancer, and hepatitis B …
- 241000711549 Hepacivirus C 0 title abstract description 228
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mehta et al. | Association between hepatitis C virus infection and diabetes mellitus | |
| Mehta et al. | Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States | |
| Arao et al. | Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus | |
| Chen et al. | Seroprevalence of hepatitis B and C in type 2 diabetic patients | |
| Booth et al. | Clinical guidelines on the management of hepatitis C | |
| Gray et al. | High prevalence of hepatitis C infection in Afro‐Caribbean patients with type 2 diabetes and abnormal liver function tests | |
| Zeuzem | Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? | |
| Imazeki et al. | Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus‐infected and hepatitis C virus‐cleared patients | |
| Seeff et al. | 45-year follow-up of hepatitis C virus infection in healthy young adults | |
| Akahane et al. | Hepatitis C virus infection in spouses of patients with type C chronic liver disease | |
| Afdhal | The natural history of hepatitis C | |
| Eyster et al. | Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) | |
| Sangiorgio et al. | Increased frequency of HCV and HBV infection in type 2 diabetic patients | |
| Herrine | Approach to the patient with chronic hepatitis C virus infection | |
| Ascione et al. | Natural history of chronic hepatitis C virus infection | |
| Lee et al. | Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications | |
| Chehadeh et al. | Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection | |
| Sagnelli et al. | Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic | |
| Sinn et al. | Disease progression and the risk factor analysis for chronic hepatitis C | |
| Kenny-Walsh | The natural history of hepatitis C virus infection | |
| Sherman et al. | Management of viral hepatitis: Clinical and public health perspectives–A Consensus Statement | |
| Akbar et al. | Prevalence of Type-2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia | |
| Brook et al. | United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015 | |
| Merchante et al. | Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus‐coinfected patients | |
| Herrine et al. | Management of patients with chronic hepatitis C infection |